| Literature DB >> 21947197 |
Carlijn T de Betue1, Doeke Boersma, Matthijs W Oomen, Marc A Benninga, Justin R de Jong.
Abstract
UNLABELLED: Chronic intestinal pseudo-obstruction syndrome (CIPS) is a severe motility disorder of the gastrointestinal tract that presents with continuous or recurrent symptoms and signs of intestinal obstruction without evidence of a structural lesion occluding the intestinal lumen. Mechanical obstruction might occur in these patients as well but is typically difficult to distinguish from an exacerbation of CIPS. We report two pediatric cases in which mechanical obstruction by volvulus mimicked an exacerbation of CIPS, requiring surgical intervention.Entities:
Mesh:
Year: 2011 PMID: 21947197 PMCID: PMC3221853 DOI: 10.1007/s00431-011-1554-y
Source DB: PubMed Journal: Eur J Pediatr ISSN: 0340-6199 Impact factor: 3.183
Fig. 1Volvulus in an 8-year-old boy with chronic intestinal pseudo-obstruction syndrome. An 8-year-old boy with chronic intestinal pseudo-obstruction syndrome presented with deteriorating symptoms of mechanical obstruction without improvement on conservative treatment. At laparotomy, an extremely dilated transverse colon with a diameter of about 20 cm was found as a result of transverse colonic volvulus
Pathogenesis of chronic intestinal pseudo-obstruction syndrome [6, 7, 10, 11]
| Entity | Affected cells | Pathogenesis | Underlying disease |
|---|---|---|---|
| Neuropathy | Enteric, sympathetic, or parasympathetic neurons | Inflammation of myenteric plexus, submucous plexus, or axons (infiltration of lymphocytes, humoral response with antineuronal bodies) | Infection, e.g., Chagas disease, CMV, or EBV infection |
| Neurological disease, e.g., encephalomyeloneuropathy | |||
| Autoimmune, e.g., scleroderma | |||
| Inflammatory diseases, e.g., inflammatory bowel disease | |||
| Paraneoplastic to, e.g., small cell carcinoma, carcinoid, neuroblastoma, thymoma | |||
| Endocrine, e.g., hypothyroidism | |||
| Other, e.g., amyloidosis | |||
| Idiopathic | |||
| Degeneration of neurons (reduction in neurons, structural abnormalities, proliferation of glial cells) | Endogenous and exogenous stimuli leading to damage and loss of enteric neurons: | ||
| e.g., altered calcium signaling, mitochondrial disorders, free radicals, and reduced gene expression of B cell lymphoma 2 gene leading to neuronal apoptosis | |||
| Hyperganglionosis | E.g. neuronal intestinal dysplasia, and MEN2B | ||
| Mesenchymopathy | ICC | Altered ICC network, i.e., decreased or increased presence of ICC and structural abnormalities | |
| Myopathy | Smooth muscle cells of the circular and longitudinal muscle layers of the intestinal wall | Abnormal architecture of muscle layers (e.g., additional muscle layer), degeneration (fibrosis, vacuolization, inclusion bodies), and α-actin abnormalities/deficiency | Primary visceral myopathy |
| Muscular dystrophy, e.g., Duchenne's disease | |||
| Myotonic dystrophy | |||
| Mitochondrial disorders, e.g., MELAS | |||
| Autoimmune disorders | |||
| Other |
CMV cytomegalovirus; EBV Epstein–Barr virus; ICC interstitial cells of Cajal; MELAS mitochondrial myopathy, encephalopathy, lactic acidosis, stroke-like episodes; MEN2B multiple endocrine neoplasia, type 2B